BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3285829)

  • 21. Comparative pharmacodynamics of torasemide and furosemide in patients with oedema.
    Herchuelz A; Deger F; Douchamps J; Ducarne H; Broekhuysen J
    Arzneimittelforschung; 1988 Jan; 38(1A):180-3. PubMed ID: 3285831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological properties of the new potent diuretic torasemide in rats and dogs.
    Ghys A; Denef J; de Suray JM; Gerin M; Georges A; Delarge J; Willems J
    Arzneimittelforschung; 1985; 35(10):1520-6. PubMed ID: 4074407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diuretic and vasodilating actions of torasemide.
    Uchida T; Yamanaga K; Kido H; Ohtaki Y; Watanabe M
    Cardiology; 1994; 84 Suppl 2():14-7. PubMed ID: 7954537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
    Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An examination of the site and mechanism of action of torasemide in man.
    Lupinacci L; Puschett JB
    J Clin Pharmacol; 1988 May; 28(5):441-7. PubMed ID: 3392242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-aldosteronergic effect of torasemide.
    Uchida T; Yamanaga K; Nishikawa M; Ohtaki Y; Kido H; Watanabe M
    Eur J Pharmacol; 1991 Nov; 205(2):145-50. PubMed ID: 1812004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Torasemide. A review of its pharmacological properties and therapeutic potential.
    Friedel HA; Buckley MM
    Drugs; 1991 Jan; 41(1):81-103. PubMed ID: 1706990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics and metabolism of torasemide in man.
    Neugebauer G; Besenfelder E; von Möllendorff E
    Arzneimittelforschung; 1988 Jan; 38(1A):164-6. PubMed ID: 3370063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the effects of torasemide and furosemide in nonazotemic cirrhotic patients with ascites: a randomized, double-blind study.
    Laffi G; Marra F; Buzzelli G; Azzena G; Meacci E; De Feo ML; La Villa G; Gentilini P
    Hepatology; 1991 Jun; 13(6):1101-5. PubMed ID: 2050329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single dose comparison of torasemide and furosemide in patients with advanced renal failure.
    Klütsch K; Grosswendt J; Haecker W
    Arzneimittelforschung; 1988 Jan; 38(1A):200-4. PubMed ID: 3285834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure.
    Goldsmith SR; Gilbertson DT; Mackedanz SA; Swan SK
    J Card Fail; 2011 Dec; 17(12):982-9. PubMed ID: 22123359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Torasemide. An update of its pharmacological properties and therapeutic efficacy.
    Dunn CJ; Fitton A; Brogden RN
    Drugs; 1995 Jan; 49(1):121-42. PubMed ID: 7705212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary excretion profile of torasemide and its diuretic action in dogs.
    Sogame Y; Okano K; Hayashi K; Uchida T; Tsuda Y
    J Pharm Pharmacol; 1996 Apr; 48(4):375-9. PubMed ID: 8794986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
    Schnackenberg CG; Merz E; Brooks DP
    Br J Pharmacol; 2003 Aug; 139(8):1383-8. PubMed ID: 12922924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Site of action of torasemide in man.
    Cuvelier R; Pellegrin P; Lesne M; van Ypersele de Strihou C
    Eur J Clin Pharmacol; 1986; 31 Suppl():15-9. PubMed ID: 3780836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure of indomethacin to impair the diuretic and natriuretic effects of the loop diuretic torasemide in healthy volunteers.
    van Ganse E; Douchamps J; Deger F; Staroukine M; Verniory A; Herchuelz A
    Eur J Clin Pharmacol; 1986; 31 Suppl():43-7. PubMed ID: 3536531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the diuretic torasemide on p-aminohippuric acid transport in the rat.
    Kramp RA; Lenoir RH; Denef J; Ghys A
    Arzneimittelforschung; 1985; 35(10):1536-41. PubMed ID: 4074410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacology of torasemide, a new loop diuretic.
    Brater DC; Leinfelder J; Anderson SA
    Clin Pharmacol Ther; 1987 Aug; 42(2):187-92. PubMed ID: 3608350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative evaluation of torasemide and furosemide on rats with streptozotocin-induced diabetic nephropathy.
    Arumugam S; Sreedhar R; Miyashita S; Karuppagounder V; Thandavarayan RA; Giridharan VV; Pitchaimani V; Afrin R; Harima M; Suzuki K; Watanabe K
    Exp Mol Pathol; 2014 Aug; 97(1):137-43. PubMed ID: 24960275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and pharmacodynamics of intravenous trasemide in mutant Nagase analbuminemic rats.
    Kim EJ; Lee MG
    Biopharm Drug Dispos; 2003 Jan; 24(1):27-35. PubMed ID: 12516076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.